The Asia Pacific PET-CT Scanner Device Market would witness market growth of 6.1% CAGR during the forecast period (2021-2027).
During a single imaging session, a positron emission tomography (PET) - computed tomography (CT) scan provides information about the structure and function of cells and tissues in the body. In recent years, many PET scans have been performed on devices that combine PET and CT scanners. In addition, the PET-CT scans together produce images that show the anatomic site of aberrant metabolic activity in the body. The results of the combined scans have been found to be more accurate than the results of the two scans taken separately.
The demand for sophisticated diagnostic technologies has increased dramatically as the world's population ages and disease incidence rises, as well as current research and development (R&D). In modern CT scanners, technological advancements in computed tomography have resulted in considerable improvements in speed, spatial resolution, and dose efficiency. The domain of radiology/imaging has been revolutionized by sophisticated and high-end devices.
Some of the key trends of the regional market are improvements in healthcare infrastructure, an increase in the number of hospitals equipped with advanced scanner devices, the development of the R&D sector, increased healthcare reforms, and technological advancements in the field of PET-CT. In addition, new product launches, mergers and acquisitions, distribution contracts, collaborations, and geographical growth by players are all happening in China and India. However, problems such as delayed manufacture owing to the COVID-19 pandemic, difficulties fitting fat people into PET-CT units, and dangerous radiation in pregnant women's units would pose serious challenges for the regional industry players.
The launch of a new accelerator system for the manufacturing of radioisotopes in Japan and Australia would help the regional population to access the advanced imaging technologies. Moreover, Radioisotope manufacturing is higher in Japan, China, India, Australia, and South Korea, which together account for the majority of the PET scanner market in Asia Pacific.
The China market dominated the Asia Pacific PET-CT Scanner Device Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $208.8 million by 2027. The Japan market is anticipated to grow at a CAGR of 5.4% during (2021 - 2027). Additionally, The India market would showcase a CAGR of 6.7% during (2021 - 2027).
Based on Slice Count, the market is segmented into Medium Slice Cardiology (64 Slices), Low Slice Cardiology (<64 Slices), and High Slice Cardiology (>64 Slices). Based on Isotope/Detector Type, the market is segmented into Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others. Based on Service Provider, the market is segmented into Hospitals, Diagnostic Centers, and Research Institutes. Based on Type, the market is segmented into Stationary Scanners and Portable Scanners/Mobile Scanners. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide PET-CT Scanner Device Market is Projected to reach USD 2.6 Billion by 2027, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Toshiba Corporation, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Shimadzu Corporation, Positron Corporation, PerkinElmer, Inc., Mediso Ltd., and Hitachi, Ltd. (Hitachi Healthcare).
By Slice Count
By Isotope/Detector Type
By Service Provider
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 